Singapore’s Sustenir has expanded its business portfolio to include functional food products, such as ready-to-drink smoothies, to support what it believes is a long-term growth opportunity.
Pacific health researchers are starting clinical trials in early 2024 to explore kava as an alternate treatment for post-traumatic stress disorder (PTSD).
New South Wales-based Renovatio Bioscience is expanding its supplement SKUs in supermarket chain Woolworths, with the company recently launching mental wellbeing and skin health supplements exclusively for the chain.
Australia company Anatara Lifesciences is trialling the use of a bromelain-containing supplement in patients suffering from irritable bowel syndrome (IBS).
India-based online marketplace Its Hemp is seeking to retail more cannabis brands on its site, and is specifically keen to launch ‘ayurvedic cannabis supplements’ designed to improve mental health issues.
Almost one-in-five Singaporeans with mental health conditions has used complementary and alternative medicine (CAM) in the past 12 months – nearly four times higher than the general population.
Taiwan's Bened Biomedical is expanding its psychobiotic business from APAC to Europe, with a new proprietary probiotic strain, as well as recent research on its established PS128 product, driving the firm's continued growth.
Morinaga Milk has announced study results showing that its proprietary probiotic, Morinaga Bifidobacterium infantis M-63, has beneficial effects on the mental health of flood victims.
Omega-3 polyunsaturated fatty acids may not have a significant impact on psychosis, according to the results of a trial led by the National Centre of Excellence in Youth Mental Health in Melbourne.
